<code id='B1668C8E4F'></code><style id='B1668C8E4F'></style>
    • <acronym id='B1668C8E4F'></acronym>
      <center id='B1668C8E4F'><center id='B1668C8E4F'><tfoot id='B1668C8E4F'></tfoot></center><abbr id='B1668C8E4F'><dir id='B1668C8E4F'><tfoot id='B1668C8E4F'></tfoot><noframes id='B1668C8E4F'>

    • <optgroup id='B1668C8E4F'><strike id='B1668C8E4F'><sup id='B1668C8E4F'></sup></strike><code id='B1668C8E4F'></code></optgroup>
        1. <b id='B1668C8E4F'><label id='B1668C8E4F'><select id='B1668C8E4F'><dt id='B1668C8E4F'><span id='B1668C8E4F'></span></dt></select></label></b><u id='B1668C8E4F'></u>
          <i id='B1668C8E4F'><strike id='B1668C8E4F'><tt id='B1668C8E4F'><pre id='B1668C8E4F'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:641

          Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

          Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

          advertisement

          You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical
          Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

          9:45AttorneyforformerPresidentDonaldTrump,JohnLauro,speakstoABC'sGeorgeStephanopoulosonAug.6,2023,in

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          'Ancient DNA,' 23andMe reveal African American ancestries

          TheIsabellafurnacestackatCatoctinFurnace,nearFrederick,Md.CourtesyCamMillerNewresearchthatcombineste